



ECMO for COVID-19 patients in Europe 
and Israel
Roberto Lorusso1,2, Alain Combes3, Valeria Lo Coco1, Maria Elena De Piero1 and Jan Belohlavek4*  on behalf of 
the EuroECMO COVID-19 WorkingGroup and Euro-ELSO Steering Committee
© 2021 The Author(s)
Dear Editor,
As of October 17th the novel coronavirus (SARS-
CoV-2) caused a pandemic disease (coronavirus disease 
2019, COVID-19) 40 million people worldwide, with 
almost one million deaths [1]. Although most patients 
have an uncomplicated clinical course, the more severe 
forms of COVID-19 require hospitalization and intensive 
care unit admission [2]. Conventional high-flow oxygen 
therapy, non-invasive and/or invasive mechanical ven-
tilation, often in combination with pronepositioning, 
have all been reported to be effective in the majority of 
patients [2]. However, in severe cases, life-threatening, 
refractory hypoxemia may occur [2]. Secondary infec-
tions, myocardial disease involvement and a hypercoagu-
able state with/without pulmonary embolism may also 
contribute to the complexity of treating these critically 
ill patients [3–5]. In such cases rescue therapy may be 
required.
The World Health Organization (WHO) [6], the Extra-
corporeal Life Support Organization (www.elso.org) and 
others have advocated the use of extracorporeal mem-
brane oxygenation (ECMO) for patients with severe car-
diorespiratory failure. Few patients in China received 
ECMO support in the early phase of the pandemic and 
the mortality rate among these patients was high [7]. Ini-
tial experience with COVID-19 in Europe was similar as 
the high number of critically ill patients disrupted usual 
care pathways and stretched hospital resources [2]. There 
was probably some hesitation to provide a form of sup-
port which is considered highly resource consuming. 
However, despite the rapid growth in the number of criti-
cally ill COVID-19 patients in Europe, over time an unex-
pectedly high number of severely compromised patients 
were considered eligible for ECMO support. At this time 
the Steering Committee of the European chapter of the 
Extracorporeal Life Support Organization (Euro-ELSO) 
initiated prospective data collection among European 
and Israeli centres with the intention of providing near 
real-time information on ECMO use in COVID-19. The 
study was approved by the Maastricht University Ethi-
cal Committee (coordinating center) and is registered 
under ClinicalTrials.gov identifier: NCT04366921. Data 
are collected weekly and reported anonymously through 
the Euro-ELSO website https ://www.euroe lso.net/covid 
-19/covid -19-surve y/. This voluntary study includes 
basic data on patients´ age and gender, the details of their 
ECMO treatment and real-time status (i.e., ongoing, suc-
cessfully weaned, or died).
Since March 15th, 2020, 177 centres from Europe and 
Israel have joined the study, routinely reporting on the 
ECMO support they provide to COVID-19 patients. The 
mean annual number of cases treated with ECMO in the 
participating centres before the pandemic (2019) was 55. 
The number of COVID-19 patients has increased rapidly 
each week reaching 1531 treated patients as of Septem-
ber 14th. The greatest number of cases has been reported 
from France (n = 385), UK (n = 193), Germany (n = 176), 
Spain (n = 166), and Italy (n = 136) (See Supplementary 
Fig. 1).
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The mean age of treated patients was 52.6  years 
(range 16–80), 79% were male. The ECMO configura-
tion used was VV in 91% of cases, VA in 5% and other 
in 4%. The mean  PaO2 before ECMO implantation was 
65 mmHg. The mean duration of ECMO support thus 
far has been 18 days and the mean ICU length of stay 
of these patients was 33  days. As of the 14th Septem-
ber, overall 841 patients have been weaned from ECMO 
support, 601 died during ECMO support, 71 died after 
withdrawal of ECMO, 79 are still receiving ECMO sup-
port and for 10 patients status n.a. (Fig. 1).
Our preliminary data suggest that patients placed 
on ECMO with severe refractory respiratory or car-
diac failure secondary to COVID-19 have a reasonable 
(55%) chance of survival. Further extensive data analy-
sis is expected to provide invaluable information on the 
demographics, severity of illness, indications and dif-
ferent ECMO management strategies in these patients.
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